Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,256,226 papers from all fields of science
Search
Sign In
Create Free Account
BMI1 Inhibitor PTC596
Known as:
PTC596
, Polycomb Ring Finger Oncogene Inhibitor PTC596
An orally active inhibitor of the polycomb ring finger oncogene BMI1 (B-cell-specific Moloney murine leukemia virus integration site 1), with…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
The Preclinical Activities of PTC596, a Novel Tubulin Binding Agent That Down-Regulates BMI1, Alone and in Combination with Bortezomib in Multiple Myeloma
Yurie Nagai
,
N. Mimura
,
+19 authors
E. Sakaida
Blood
2019
Corpus ID: 209289703
Introduction: A novel tubulin binding agent PTC596, which is currently in clinical trials for solid tumors, was originally…
Expand
2019
2019
S122 THE FIRST-IN-CLASS, ORALLY AVAILABLE BMI-1 MODULATORS PTC-028 AND PTC596 DISPLAY POTENT ACTIVITY IN PRE-CLINICAL MODELS OF MULTIPLE MYELOMA
A. Bolomsky
,
J. Muller
,
+12 authors
H. Ludwig
HemaSphere
2019
Corpus ID: 196564090
2019
2019
The first-in-class BMI-1 modulators PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma
A. Bolomsky
,
J. Muller
,
+8 authors
H. Ludwig
Clinical Lymphoma, Myeloma & Leukemia
2019
Corpus ID: 208412994
2018
2018
Preclinical studies of BMI-1 modulator PTC596 in diffuse intrinsic pontine gliomas, pediatric high-grade gliomas and medulloblastoma.
S. Kumar
,
A. Adile
,
+11 authors
R. Drissi
2018
Corpus ID: 81386910
e14051Background: Diffuse intrinsic pontine glioma (DIPG) is a universally fatal brainstem tumor with survival < 1 year despite…
Expand
2018
2018
DIPG-13. SENSITIVITY OF DIPG CELLS TO BMI-1 MODULATOR PTC596 IS INDEPENDENT OF EZH2 ACTIVITY
S. Kumar
,
Satarupa Sengupta
,
Kyungwoo Lee
,
R. Drissi
Neuro-Oncology
2018
Corpus ID: 81349878
2018
2018
Abstract 5864: Novel anti-BMI-1 therapy in non-small cell lung cancer
Indira Krishnan
,
Giorgia Maroni
,
+21 authors
E. Levantini
Experimental and Molecular Therapeutics
2018
Corpus ID: 80994203
Lung cancer represents one of the most significant and lethal diseases worldwide. Advances in treatment protocols, the…
Expand
2016
2016
Phase 1 results of PTC596, a novel small molecule targeting cancer stem cells (CSCs) by reducing levels of BMI1 protein
G. Shapiro
,
P. Bedard
,
+8 authors
R. Spiegel
2016
Corpus ID: 78534794
2012
2012
511 Identification of a Small Molecule (PTC596) That Preferentially Depletes Tumor Stem Cells by Reducing Levels of Functional BMI1 Protein
T. Davis
,
S. Lee
,
+7 authors
Liang Cao
2012
Corpus ID: 74835426
2011
2011
ポリコーム群遺伝子 Bmi1 による造血幹細胞の運命決定制御
小黒 秀行
,
中内 啓光
,
岩間 厚志
2011
Corpus ID: 83401366
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required